TELA Bio, Inc. (NASDAQ: TELA) reported Q3 EPS of ($0.45), $0.03 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $15.1 million versus the consensus estimate of $16.2 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.